Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis - No Study Results Posted

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis (ILODOSE)

This study has been terminated.

( sufficient number to reach the primary endpoint and as planned )

Study NCT00622687 Information provided by Charite University, Berlin, Germany

First Received: February 14, 2008 Last Updated: February 22, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	December 2007
Primary Completion Date:	December 2003 (Final data collection date for primary outcome measure)

No publications provided by Charite University, Berlin, Germany

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kawald A, Burmester GR, Huscher D, Sunderkötter C, Riemekasten G. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study. J Rheumatol. 2008 Sep;35(9):1830-7. Epub 2008 Jul 15.